Literature DB >> 29728768

Therapeutic decisions in ALS patients: cross-cultural differences and clinical implications.

Peter M Andersen1, Magdalena Kuzma-Kozakiewicz2,3, Jürgen Keller4, Helena E A Aho-Oezhan4, Katarzyna Ciecwierska2, Natalia Szejko2, Cynthia Vázquez4, Sarah Böhm4, Gisela Badura-Lotter5, Thomas Meyer6, Susanne Petri7, Katharina Linse8, Andreas Hermann8, Olof Semb9, Erica Stenberg1, Simona Nackberg9, Johannes Dorst4, Ingo Uttner4, Ann-Cristin Häggström1, Albert C Ludolph10, Dorothée Lulé4.   

Abstract

OBJECTIVE: Quantitative analysis of decision-making on therapeutic options in different sociocultural context in amyotrophic lateral sclerosis (ALS).
METHODS: ALS patients (n = 244) were consecutively recruited in Germany (n = 83), Poland (n = 83), and Sweden (n = 78) in a prospective cross-cultural study ( www.NEEDSinALS.com ). They were interviewed on preferences for therapeutic techniques including invasive (IV) and non-invasive ventilation (NIV), as well as percutaneous endoscopic gastrostomy (PEG) and on hypothetical termination of these using quantitative questions. Using standardized questionnaires, religiousness, personal values, quality of life, and depressiveness were assessed.
RESULTS: NIV was most frequently used in Germany and PEG in Sweden. Swedish patients were most liberal on initiation and termination of PEG, NIV and IV. Polish patients were mostly undecided and were least likely to consider discontinuing supportive management. Current use was partly associated with age, gender and state of physical function; also, financial support explained some variance. Future preferences on therapeutic options from the patient's perspective were also closely associated with cultural factors. The more oriented towards traditional and conservative values, the less likely patients were to decide for invasive therapeutic devices (IV, PEG), the least likely to have ideations to discontinue any device and the more likely to have an undecided attitude.
CONCLUSIONS: Current use of therapeutic options is determined by medical condition in analogy to clinical guidelines. For future considerations, other factors such as cultural background are crucial, yielding hurdles to be regarded in the implementation of advanced directives in a multicultural environment.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Culture; Decision; Medical care; Palliative care; Quality of life

Mesh:

Year:  2018        PMID: 29728768     DOI: 10.1007/s00415-018-8861-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  27 in total

Review 1.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

Review 2.  End-of-life management in patients with amyotrophic lateral sclerosis.

Authors:  Sheelah Connolly; Miriam Galvin; Orla Hardiman
Journal:  Lancet Neurol       Date:  2015-02-27       Impact factor: 44.182

3.  The Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen: a cross-sectional comparison of established screening tools in a German-Swiss population.

Authors:  Dorothée Lulé; Christian Burkhardt; Susanne Abdulla; Sarah Böhm; Katja Kollewe; Ingo Uttner; Sharon Abrahams; Thomas H Bak; Susanne Petri; Markus Weber; Albert C Ludolph
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-10-08       Impact factor: 4.092

4.  Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients' perspectives.

Authors:  L P Greenaway; N H Martin; V Lawrence; A Janssen; A Al-Chalabi; P N Leigh; L H Goldstein
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

5.  Nutritional status is a prognostic factor for survival in ALS patients.

Authors:  J C Desport; P M Preux; T C Truong; J M Vallat; D Sautereau; P Couratier
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

6.  EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.

Authors:  Peter M Andersen; Sharon Abrahams; Gian D Borasio; Mamede de Carvalho; Adriano Chio; Philip Van Damme; Orla Hardiman; Katja Kollewe; Karen E Morrison; Susanne Petri; Pierre-Francois Pradat; Vincenzo Silani; Barbara Tomik; Maria Wasner; Markus Weber
Journal:  Eur J Neurol       Date:  2011-09-14       Impact factor: 6.089

Review 7.  End of life decisions in amyotrophic lateral sclerosis: a cross-cultural perspective.

Authors:  A Smyth; M Riedl; R Kimura; R Olick; M Siegler
Journal:  J Neurol Sci       Date:  1997-10       Impact factor: 3.181

Review 8.  Tracheostomy and invasive mechanical ventilation in amyotrophic lateral sclerosis: decision-making factors and survival analysis.

Authors:  Fumiharu Kimura
Journal:  Rinsho Shinkeigaku       Date:  2016-03-30

9.  Quality of life and psychosocial issues in ventilated patients with amyotrophic lateral sclerosis and their caregivers.

Authors:  Dagmar Kaub-Wittemer; Nicole von Steinbüchel; Maria Wasner; Gerhard Laier-Groeneveld; Gian Domenico Borasio
Journal:  J Pain Symptom Manage       Date:  2003-10       Impact factor: 3.612

Review 10.  Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach.

Authors:  Anne Hogden; Geraldine Foley; Robert D Henderson; Natalie James; Samar M Aoun
Journal:  J Multidiscip Healthc       Date:  2017-05-19
View more
  7 in total

1.  Associative Increases in Amyotrophic Lateral Sclerosis Survival Duration With Non-invasive Ventilation Initiation and Usage Protocols.

Authors:  Nishad Khamankar; Grant Coan; Barry Weaver; Cassie S Mitchell
Journal:  Front Neurol       Date:  2018-07-12       Impact factor: 4.003

2.  Psychological flexibility and attitudes toward evidence-based interventions by amyotrophic lateral sclerosis patients.

Authors:  James R Pearlman; Einar B Thorsteinsson
Journal:  PeerJ       Date:  2019-02-26       Impact factor: 2.984

3.  An observational study on quality of life and preferences to sustain life in locked-in state.

Authors:  Magdalena Kuzma-Kozakiewicz; Peter M Andersen; Katarzyna Ciecwierska; Cynthia Vázquez; Olga Helczyk; Markus Loose; Ingo Uttner; Albert C Ludolph; Dorothée Lulé
Journal:  Neurology       Date:  2019-08-07       Impact factor: 9.910

4.  Disease progression but not physical state per se determines mental wellbeing in ALS.

Authors:  Cynthia R Vázquez Medrano; Helena E A Aho-Özhan; Ulrike Weiland; Ingo Uttner; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2020-07-08       Impact factor: 4.849

5.  Caregivers' View of Socio-Medical Care in the Terminal Phase of Amyotrophic Lateral Sclerosis-How Can We Improve Holistic Care in ALS?

Authors:  Katharina Linse; Elisa Aust; René Günther; Andreas Hermann
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

Review 6.  Talking about the end of life: communication patterns in amyotrophic lateral sclerosis - a scoping review.

Authors:  Anke Erdmann; Celia Spoden; Irene Hirschberg; Gerald Neitzke
Journal:  Palliat Care Soc Pract       Date:  2022-03-15

7.  Trends and outcomes associated with gastrostomy tube placement in common neurodegenerative disorders.

Authors:  Duk Soo Kim; Richard N Jones; Theresa I Shireman; Benzi M Kluger; Joseph H Friedman; Umer Akbar
Journal:  Clin Park Relat Disord       Date:  2020-12-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.